Know the Role of Colchicine for Chronic Coronary Disease

December 2023

You’ll hear buzz about new Rx colchicine (Lodoco) for patients with chronic coronary disease.

There’s been growing interest in using colchicine to reduce CV risk...due to its anti-inflammatory effect.

Lodoco is the same drug we use for gout...but it’s 0.5 mg instead of 0.6 mg. And it’s the first colchicine approved to reduce CV risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Antihypertensives Answer Common Questions About First-Line BP Meds
Hypertension Use a Conservative Approach for Most Inpatient Hypertension
Naloxone Compare Nalmefene and Naloxone for Opioid Overdose Reversal
Diabetes Navigate Risk of Ketoacidosis Due to an SGLT2 Inhibitor
Cardiology Know the Role of Colchicine for Chronic Coronary Disease
Infectious Diseases Give Guidance About At-Home Tests for Respiratory Viruses
Communication Continue to Reinforce Using Inclusive Language
NatMed Spotlight Be on the Lookout for Interactions With St. John’s Wort